CLINICAL_TRIALS
trial_result
· 2024-06-11
Clinical Trial Update: Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus [Phase 2]
Summary
A Phase 2 trial evaluating baricitinib for treating cutaneous lichen planus has completed, with results posted in June 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aaron R. Mangold | Conditions: Cutaneous Lichen Planus | Phase 2 | Status: COMPLETED | Results posted: 2024-06-11